Marshall Wace LLP bought a brand new stake in Xponential Health, Inc. (NYSE:XPOF – Get Score) within the third quarter, in accordance with its most up-to-date disclosure with the Securities & Change Fee. The institutional investor bought 235,537 shares of the corporate’s inventory, valued at roughly $4,301,000. Marshall Wace LLP owned roughly 0.48% of Xponential Health as of its most up-to-date SEC submitting.
→ High Inventory To Watch (From Press Attain)
A number of different hedge funds additionally not too long ago added to or decreased their stakes in XPOF. Macquarie Group Ltd. boosted its holdings in shares of Xponential Health by 23.1% within the third quarter. Macquarie Group Ltd. now owns 3,320 shares of the corporate’s inventory valued at $61,000 after shopping for a further 624 shares within the final quarter. American Worldwide Group Inc. grew its holdings in shares of Xponential Health by 23.9% throughout the first quarter. American Worldwide Group Inc. now owns 6,115 shares of the corporate’s inventory value $143,000 after buying a further 1,181 shares over the last quarter. Brown Advisory Inc. elevated its place in shares of Xponential Health by 12.2% throughout the second quarter. Brown Advisory Inc. now owns 11,802 shares of the corporate’s inventory value $148,000 after buying a further 1,279 shares within the final quarter. MetLife Funding Administration LLC lifted its holdings in shares of Xponential Health by 27.3% within the third quarter. MetLife Funding Administration LLC now owns 10,430 shares of the corporate’s inventory valued at $190,000 after buying a further 2,234 shares over the last quarter. Lastly, Point72 Hong Kong Ltd acquired a brand new stake in shares of Xponential Health within the 2nd quarter valued at about $34,000. 28.77% of the inventory is presently owned by hedge funds and different institutional buyers.
Xponential Health Inventory Down 1.1 %
Shares of NYSE:XPOF opened at $27.33 on Tuesday. Xponential Health, Inc. has a 52 week low of $11.20 and a 52 week excessive of $30.70. The corporate has a 50-day shifting common value of $25.94 and a 200 day shifting common value of $22.22. The corporate has a market cap of $1.35 billion, a P/E ratio of -7.45, a PEG ratio of 1.30 and a beta of 1.41.
Analyst Upgrades and Downgrades
A number of analysis companies have commented on XPOF. B. Riley boosted their value goal on Xponential Health from $30.00 to $32.00 and gave the corporate a “purchase” ranking in a analysis notice on Friday, January thirteenth. Guggenheim elevated their value goal on shares of Xponential Health from $29.00 to $31.00 in a analysis notice on Monday. Morgan Stanley raised their value goal on shares of Xponential Health from $28.00 to $30.00 and gave the inventory an “chubby” ranking in a analysis report on Friday, March third. Robert W. Baird upped their goal value on shares of Xponential Health from $32.00 to $34.00 in a report on Friday, March third. Lastly, Raymond James raised their value goal on Xponential Health from $30.00 to $32.00 and gave the inventory a “strong-buy” ranking in a report on Friday, March third. Six analysts have rated the inventory with a purchase ranking and one has issued a robust purchase ranking to the corporate’s inventory. In keeping with MarketBeat, Xponential Health has a consensus ranking of “Purchase” and a mean goal value of $32.63.
Insider Transactions at Xponential Health
In associated information, Director Mark Grabowski bought 4,000,000 shares of the corporate’s inventory in a transaction on Friday, February tenth. The inventory was bought at a mean value of $24.50, for a complete transaction of $98,000,000.00. Following the transaction, the director now owns 10,472 shares of the corporate’s inventory, valued at $256,564. The sale was disclosed in a submitting with the Securities & Change Fee, which is obtainable at this hyperlink. In different Xponential Health information, Director Mark Grabowski bought 4,000,000 shares of the corporate’s inventory in a transaction dated Friday, February tenth. The shares have been bought at a mean value of $24.50, for a complete transaction of $98,000,000.00. Following the transaction, the director now immediately owns 10,472 shares within the firm, valued at $256,564. The sale was disclosed in a doc filed with the Securities & Change Fee, which is obtainable at this hyperlink. Additionally, COO Ryan Junk bought 10,290 shares of Xponential Health inventory in a transaction that occurred on Thursday, March ninth. The shares have been bought at a mean value of $28.55, for a complete transaction of $293,779.50. Following the sale, the chief working officer now owns 14,660 shares of the corporate’s inventory, valued at $418,543. The disclosure for this sale could be discovered right here. Within the final three months, insiders bought 5,870,735 shares of firm inventory valued at $144,519,681. Company insiders personal 69.33% of the corporate’s inventory.
Xponential Health Profile
(Get Score)
Xponential Health, Inc, by way of its subsidiaries, operates as a boutique health franchisor in the USA and internationally. The corporate affords health and wellness companies, together with pilates, barre, biking, stretching, rowing, yoga, boxing, dancing, operating, and practical coaching beneath the Membership Pilates, Pure Barre, CycleBar, StretchLab, Row Home, YogaSix, Rumble, AKT, Stride, and BFT manufacturers.
Learn Extra
This immediate information alert was generated by narrative science expertise and monetary knowledge from MarketBeat with the intention to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial group previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you contemplate Xponential Health, you may need to hear this.
MarketBeat retains monitor of Wall Road’s top-rated and greatest performing analysis analysts and the shares they advocate to their shoppers each day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Xponential Health wasn’t on the checklist.
Whereas Xponential Health presently has a “Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
View The 5 Shares Right here
